Company Announcements

Director/PDMR Shareholding

Source: RNS
RNS Number : 7558R
Marlowe PLC
07 July 2022
 

7 July 2022

 

Marlowe plc

 

Director/PDMR Shareholding

 

Marlowe plc ("Marlowe", the "Group" or the "Company"), the UK leader in business-critical services and software which assure safety and regulatory compliance, announces that Rachel Addison, Non-Executive Director of the Company, purchased 12,922 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 770 pence per Ordinary Share on 7 July 2022.

 

As a result, Rachel Addison is now interested in 12,922 Ordinary Shares, representing approximately 0.01% of the Company's issued ordinary share capital.

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation (596/2014), provides further details.

 

For further information:

 

Marlowe plc


Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 841 6194

Julian Wais, Head of Investor Relations

IR@marloweplc.com

Benjamin Tucker, Investor Relations Manager




 

Cenkos Securities plc - Nominated Adviser and Joint Broker

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

George Lawson


 

Joh. Berenberg, Gossler & Co. KG, London Branch - Joint Broker

Mark Whitmore

Ben Wright

Tel: +44 (0)20 3207 7800

 

 

Stifel - Joint Broker

Matthew Blawat

Francis North

Tel: +44 (0)20 7710 7688

 

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

About Marlowe plc


Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on compliance software, eLearning, health & safety, employment law and HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets and leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rachel Addison

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Purchase of ordinary shares

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




770   pence

 

12,922







d)

 

Aggregated information

 N/A single transaction

- Aggregated volume


- Price


e)

Date of the transaction

7 July 2022

 

f)

Place of the transaction

AIMX

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGGNVNLGZZM